Abstract
As the human race is still threatened by prospective avian flu endemics, new motivations and systematic approaches should be placed high on agenda in order to alleviate the potential losses of both human life and local economics. A balance and comprehensive measures between economy and the ecosystem of the endemic regions must also be considered. One of the top priorities in these explorations should be effective therapy for infected patients, including better uses and applications of vaccines and antiviral agents. In order to be better prepared for prospective avian flu epidemics, experimental and theoretical inquiry of therapeutic and technical feasibilities against avian viruses in humans deserve to be priority concerned, and extensive experimental and clinical exploitations of fatal pathogenesis of virus infection in human cells at genetic and cytological levels, are urgently needed. In this review, we address and discuss these important questions and review some important solutions for avian flu in future, including antiviral agents, virus vaccinations, Chinese medicine and genetic treatment of the disease.
Keywords: Avian flu, influenza virus, viral pathogenesis, viral treatment, antiviral agents, viral vaccine, human genome, viral genetic pathogenesis, traditional Chinese medicine, medicinal chemistry, neuraminidase inhibitors
Anti-Infective Agents
Title:Avian Flu; Pathogenesis and Therapy
Volume: 10 Issue: 2
Author(s): Da-Yong Lu, Ting-Ren Lu and Hong-Ying Wu
Affiliation:
Keywords: Avian flu, influenza virus, viral pathogenesis, viral treatment, antiviral agents, viral vaccine, human genome, viral genetic pathogenesis, traditional Chinese medicine, medicinal chemistry, neuraminidase inhibitors
Abstract: As the human race is still threatened by prospective avian flu endemics, new motivations and systematic approaches should be placed high on agenda in order to alleviate the potential losses of both human life and local economics. A balance and comprehensive measures between economy and the ecosystem of the endemic regions must also be considered. One of the top priorities in these explorations should be effective therapy for infected patients, including better uses and applications of vaccines and antiviral agents. In order to be better prepared for prospective avian flu epidemics, experimental and theoretical inquiry of therapeutic and technical feasibilities against avian viruses in humans deserve to be priority concerned, and extensive experimental and clinical exploitations of fatal pathogenesis of virus infection in human cells at genetic and cytological levels, are urgently needed. In this review, we address and discuss these important questions and review some important solutions for avian flu in future, including antiviral agents, virus vaccinations, Chinese medicine and genetic treatment of the disease.
Export Options
About this article
Cite this article as:
Lu Da-Yong, Lu Ting-Ren and Wu Hong-Ying, Avian Flu; Pathogenesis and Therapy, Anti-Infective Agents 2012; 10 (2) . https://dx.doi.org/10.2174/2211362611208020124
DOI https://dx.doi.org/10.2174/2211362611208020124 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Passive Smoking, Asthma and Allergy in Children
Inflammation & Allergy - Drug Targets (Discontinued) Lone Atrial Fibrillation- A Diagnosis of Exclusion
Current Pharmaceutical Design Gold Nanoparticles in Cancer Therapy: Efficacy, Biodistribution, and Toxicity
Current Pharmaceutical Design Regulatory T Cell Counts and Development of Malignancy in Patients with HIV Infection
Current HIV Research Emerging Role of CD44 Receptor as a Potential Target in Disease Diagnosis: A Patent Review
Recent Patents on Inflammation & Allergy Drug Discovery Endogenous Repair System of Oxidative Damage of DNA
Current Chemical Biology Mechanisms of Protein Aggregation
Current Pharmaceutical Biotechnology Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design Identification of HLA-A11-Restricted HIV-1-Specific Cytotoxic Tlymphocyte Epitopes in China
Current HIV Research Nigella sativa L. and Its Bioactive Constituents as Hepatoprotectant: A Review
Current Pharmaceutical Biotechnology Glucose Metabolism and Antidepressant Medication
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Endothelin-1 and Human Platelets
Current Vascular Pharmacology Therapeutic Targeting of Melanoma Cells Using Neural Stem Cells Expressing Carboxylesterase, a CPT-11 Activating Enzyme
Current Stem Cell Research & Therapy Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment
Clinical Cancer Drugs Formulation and Application of Biodegradable Nanoparticles Based Biopharmaceutical Delivery - An Efficient Delivery System
Current Pharmaceutical Design Targeting the BRCA1/2 Tumor Suppressors
Current Drug Targets The Impact of Bacterial Lipolysaccharides on the Endothelial System: Pathological Consequences and Therapeutic Countermeasures
Endocrine, Metabolic & Immune Disorders - Drug Targets The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders
CNS & Neurological Disorders - Drug Targets Immunosuppressive Therapies in Solid Organ Transplantation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)